Our management

Michael joined Hikma’s US subsidiary West-Ward from Vitarine Pharmaceuticals where he had worked from 1984 until 1992 in various roles, including Vice President, Quality Control.  Prior to this, Michael worked at Schering-Plough and Hoffman LaRoche. At Hikma Michael has previously been responsible for all West-Ward’s operations as well as quality/compliance for all worldwide Hikma facilities until his appointment as President and CEO of West-Ward in 2008.

Michael holds a Masters degree in Industrial Pharmacy from Long Island University and a Bachelor's degree in Chemistry from St. Francis College.  Michael is also a graduate of INSEAD's International Executive Program.

Riad joined Hikma as a Project Engineer in the engineering department where he was involved in the construction of Hikma’s facility in Portugal. Riad spent a significant period in the manufacturing operations of many Hikma sites, was general manager of Hikma Italy and became Head of Injectables Manufacturing Operations before assuming his current role. Riad was an executive director at Watson Pharmaceuticals from 1998 to 2005, responsible for Injectables operations. Riad has led the injectables divisional through a period of rapid growth and has integrated operations into a global operation.

Riad has a BSc in Engineering and a Masters in Engineering and Management from George Washington University.

Prior to assuming his current role, Khalid held several senior positions in the Hikma finance department including Corporate Vice President, Finance and was a key member of the IPO team in 2005. Following qualification as a CPA he held a variety of roles in financial accounting, reporting and financial advisory services, and with Atlas Investment Group (now AB Invest) where he was involved in mergers and acquisitions advisory services. Prior to Atlas, Khalid had managed several multinational audit engagements at Arthur Andersen in Amman, Jordan.  As Chief Financial Officer, Khalid has integrated several acquisitions into the financial reporting structure, developed the group internal control framework and implemented new leverage arrangements to fund acquisitions and capital investment.

Khalid is a US Certified Public Accountant and has an MBA from the University of Hull.

During her 28 years at Hikma, Majda has held a variety of roles including Purchasing Manager at Hikma Pharmaceuticals Limited, Strategy Manager at Hikma Investment, General Manager of Hikma Farmaceutica and Vice President of Injectables. In February 2009 Majda assumed her current position as Corporate Vice President, Human Resources. She has been responsible for establishing a central human resource practice and leading the development of several group wide initiatives, including the grading structure, performance evaluation process and the group bonus scheme.

Majda has completed the Advanced Management Program (AMP) program at INSEAD, holds a BA from the American University of Beirut and masters degree from Hochschule Fur Okonomie in Berlin, Germany.

Since joining Hikma, Henry has advised on all legal aspects of the Group’s business, including commercial negotiations, litigation and regulatory matters as well as contributing to the execution of the Group’s acquisitions. More recently Henry has been responsible for developing the group’s enhanced corporate compliance programme. Before joining Hikma, Henry worked for the international law firm, Ashurst, where he specialized in mergers & acquisitions, equity capital markets and corporate law.

Henry is admitted as a solicitor in England and Wales and holds an MA in Social and Political Science from Trinity College, Cambridge.

Susan joined Hikma as Investor Relations Director, having previously worked for the pharmaceutical distribution and retail pharmacy group Alliance UniChem plc as Investor Relations Manager.  She also has experience as an equity analyst at Morgan Stanley in London.  In early 2012 Susan assumed responsibility for corporate strategy.

Susan holds a BA in History from Cornell University and an MBA from London Business School.

Peter joined Hikma as a Deputy Company Secretary in 2010. Prior to joining Hikma, he worked in the Corporate Secretariat of Barclays and Pool Re, the UK terrorism re-insurer. He also worked at Manifest, a leading Corporate Governance Agency. In 2012, Peter assumed the role of Company Secretary. Peter is responsible for advising on governance at the board and across the group, as well as the share-based compensation arrangements.

Peter is a Fellow of the institute of Chartered Secretaries and Administrators and holds a law degree from University of East Anglia.

Ibrahim joined Hikma as Technical Director and has held a variety of roles including Corporate Technical Vice President for Compliance and Senior Corporate Vice President for R&D.  He has played a leading role in Hikma securing FDA approval for its manufacturing units.

Ibrahim holds a PhD in Pharmacy from the University of Wisconsin-Madison.

Fadi has worked in various roles within the Group including Operations, Purchasing and Business Development. He was promoted to Corporate Vice President, API in 2007. Fadi is a Director of Hubei Haosun Pharmaceutical Co. Ltd., an Active Pharmaceutical Ingredient manufacturing company in which Hikma purchased a significant minority interest in 2011.

Fadi holds a BSc in Chemical Engineering from Newcastle University and an MSc in Chemical Engineering from Leeds University. Fadi is also a graduate of INSEAD’s International Executive Program.